DK43890D0 - Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse - Google Patents

Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse

Info

Publication number
DK43890D0
DK43890D0 DK043890A DK43890A DK43890D0 DK 43890 D0 DK43890 D0 DK 43890D0 DK 043890 A DK043890 A DK 043890A DK 43890 A DK43890 A DK 43890A DK 43890 D0 DK43890 D0 DK 43890D0
Authority
DK
Denmark
Prior art keywords
nucleic acid
vectors
cells containing
produced products
peptides
Prior art date
Application number
DK043890A
Other languages
Danish (da)
English (en)
Other versions
DK43890A (da
Inventor
Raymond Alan Brian Ezekowitz
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22206319&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK43890(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Publication of DK43890D0 publication Critical patent/DK43890D0/da
Publication of DK43890A publication Critical patent/DK43890A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/24—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK043890A 1987-08-20 1990-02-19 Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse DK43890A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8762887A 1987-08-20 1987-08-20
PCT/US1988/002591 WO1989001519A1 (fr) 1987-08-20 1988-08-05 Proteine humaine liant le mannose

Publications (2)

Publication Number Publication Date
DK43890D0 true DK43890D0 (da) 1990-02-19
DK43890A DK43890A (da) 1990-02-19

Family

ID=22206319

Family Applications (1)

Application Number Title Priority Date Filing Date
DK043890A DK43890A (da) 1987-08-20 1990-02-19 Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse

Country Status (7)

Country Link
EP (1) EP0375736B1 (fr)
JP (1) JP2868777B2 (fr)
AT (1) ATE165980T1 (fr)
DE (1) DE3856180T2 (fr)
DK (1) DK43890A (fr)
FI (1) FI900808A0 (fr)
WO (1) WO1989001519A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006010A1 (fr) * 1989-10-11 1991-05-02 Institute Of Child Health Procedure de diagnostic
GB9023907D0 (en) * 1990-11-02 1990-12-12 Mallucci Livio Cell growth inhibitors
JPH06501620A (ja) * 1990-11-06 1994-02-24 ザ・チルドレンズ・メディカル・センター・コーポレイション 可溶性マンノース受容体ペプチド
CA2056118A1 (fr) * 1990-12-24 1992-06-25 Kendra B. Eager Anticorps monoclonaux qui lient la proteine fixatrice du mannose
DK0598719T3 (da) * 1991-07-31 1999-06-14 Antex Biolog Inc Receptorkonjugater til destinering af lægemidler og andre midler
EP0842297A1 (fr) 1995-07-27 1998-05-20 IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY & MEDICINE Procedes de prediction de l'evolution d'infections
CN1106846C (zh) * 1997-08-21 2003-04-30 宝酒造株式会社 抗癌症剂
JP3878737B2 (ja) 1998-01-23 2007-02-07 扶桑薬品工業株式会社 新規コレクチン
US7049099B2 (en) 1998-01-23 2006-05-23 Fuso Pharmaceutical Industries, Ltd. Recombinant human mannan-binding proteins and producing method of the same
JPH11206378A (ja) 1998-01-23 1999-08-03 Fuso Pharmaceutical Industries Ltd 組換えヒトマンナン結合タンパク質およびその製造方法
JP4707231B2 (ja) * 1998-06-10 2011-06-22 スタテンズ セーラム インスティテュート マンナン結合レクチンを製造するための精製方法及びｍｂｌ医薬品
JP2002532079A (ja) * 1998-12-15 2002-10-02 ザ ブライハム アンド ウイミンズ ホスピタル， インコーポレイテッド 補体活性化に関連するレクチン補体経路を調節するための方法および産物
US7273925B1 (en) 1998-12-15 2007-09-25 Brigham And Women's Hospital, Inc. Methods and products for regulating lectin complement pathway associated complement activation
WO2000070043A1 (fr) 1999-05-14 2000-11-23 Steffen Thiel Lectine humaine de recombinaison se fixant a la mannane
CN1899603B (zh) * 1999-05-14 2010-09-08 斯蒂芬·蒂尔 甘露聚糖-结合型凝集素(mbl)在免疫受损个体的治疗中的新意义
CN100485035C (zh) 2000-02-14 2009-05-06 扶桑药品工业株式会社 新型清除蛋白受体
DE60126602T2 (de) 2000-04-21 2007-11-22 Fuso Pharmaceutical Industries, Ltd. Neue collectine
DK1303591T3 (da) * 2000-07-13 2009-11-02 Helion Biotech Aps MASP-2, et komplementfikserende enzym, og anvendelser af det
EP1186299A1 (fr) * 2000-09-12 2002-03-13 Universitair Medisch Centrum Utrecht Diagnostic, prévention et/ou traitement d' athérosclérose, infections et perturbations du système immunitaire
WO2007085057A1 (fr) * 2006-01-25 2007-08-02 The Council Of The Queensland Institute Of Medical Research Protocole médical
WO2007095154A2 (fr) 2006-02-10 2007-08-23 The Brigham And Women's Hospital, Inc. Dosages de la voie du complement de la lectine et compositions et procedes associes
SG10201503351RA (en) 2010-01-19 2015-06-29 Harvard College Engineered Opsonin for Pathogen Detection and Treatment
CA2842321C (fr) 2011-07-18 2022-05-03 President And Fellows Of Harvard College Molecules manipulees ciblant un microbe et leurs utilisations
WO2013130875A1 (fr) 2012-02-29 2013-09-06 President And Fellows Of Harvard College Test rapide de sensibilité aux antibiotiques
US10551379B2 (en) 2013-03-15 2020-02-04 President And Fellows Of Harvard College Methods and compositions for improving detection and/or capture of a target entity
CA2913155A1 (fr) 2013-05-21 2014-11-27 President And Fellows Of Harvard College Compositions se liant a l'heme manipulees et leurs utilisations
EP3083658B1 (fr) 2013-12-18 2019-05-08 President and Fellows of Harvard College Détection de bacteries gram positif à l'aide de crp
EP3763378A1 (fr) 2015-08-06 2021-01-13 President and Fellows of Harvard College Molécules améliorées aptes à se lier à des microbes, et leurs utilisations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU573529B2 (en) * 1982-05-12 1988-06-16 President And Fellows Of Harvard College Hybrid proteins

Also Published As

Publication number Publication date
DE3856180D1 (de) 1998-06-18
WO1989001519A1 (fr) 1989-02-23
DK43890A (da) 1990-02-19
EP0375736A1 (fr) 1990-07-04
FI900808A0 (fi) 1990-02-19
JP2868777B2 (ja) 1999-03-10
JPH02504581A (ja) 1990-12-27
ATE165980T1 (de) 1998-05-15
EP0375736B1 (fr) 1998-05-13
DE3856180T2 (de) 1998-09-03

Similar Documents

Publication Publication Date Title
DK43890D0 (da) Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse
IS4416A (is) Líkamsþyngdarstillar (modulators), samsvarandi kjarnsýrur og prótein, og notkun þeirra við sjúkdómsgreiningar og í læknismeðhöndlun
DK382786D0 (da) Overfladeaktivt rekombinant-alveolarprotein
ATE126441T1 (de) Pentigetide zur behandlung von nicht-ige- vermittelten entzündlichen erkrankungen.
DE68929551D1 (de) Menschliche DNase
DE3683482D1 (de) Cdns und gen fuer menschliches angiogenin (angiogenesis-faktor) und expression.
ATE352559T1 (de) Verfahren zur verminderung der immunogenität von proteinen
DE69634912D1 (de) Intrazellulare domäne des her-2/neu proteins, für die prevention oder behandlung von bösartigen tumoren
DE3578611D1 (de) Instrumente zur behandlung von verformten naegeln bei menschlichen patienten.
DK0784703T3 (da) Lamininkæder: Diagnostisk og terapeutisk anvendelse
NO960309L (no) Agonister og antagonister for humaninterleukin-10
DE68925226D1 (de) Monoklonale Antikörper
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
DK235687A (da) Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse deraf
IL87391A0 (en) Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
FI913818A0 (fi) Nytt trombolytiskt aemne.
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
SE9002212D0 (sv) Igg binding protein
GEP20043386B (en) β -Amyloid Peptide-Binding Proteins and Polynucleotides Encoding the Same
EP0315081A3 (en) Anti-coagulating protein pp4-x, its preparation and use
DE3765916D1 (de) Sonde zur einfuehrung in den verdauungs- oder ausscheidungstrakt des menschlichen oder tierischen koerpers, insbesondere lithotriptor-sonde.
NO900745L (no) Humant mannose-bindende protein.
DE59611330D1 (de) Arzneimittel enthaltend wenigstens einen teil des ul84-proteins des cytomegalovirus, verwendung von polypeptiden entsprechend der aminosäuresequenz des ul84-proteins und verfahren zur einführung von ul84 in zielzellen
NO880825D0 (no) Dietetisk styrke- og helbredelsesmiddel for behandling av den helhetlige organismen hos mennesker og dyr.
ATE223227T1 (de) Verwendung von lbp zur sepsistherapie

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment